Long Pond Capital LP acquired a new position in Omega Healthcare Investors Inc (NYSE:OHI) in the second quarter, Holdings Channel reports. The fund acquired 1,310,279 shares of the real estate investment trust’s stock, valued at approximately $48,153,000. Omega Healthcare Investors makes up approximately 1.4% of Long Pond Capital LP’s investment portfolio, making the stock its 18th biggest position.
A number of other large investors have also modified their holdings of the stock. US Bancorp DE raised its stake in Omega Healthcare Investors by 1.6% in the second quarter. US Bancorp DE now owns 26,963 shares of the real estate investment trust’s stock worth $991,000 after buying an additional 435 shares in the last quarter. Trinity Legacy Partners LLC grew its holdings in Omega Healthcare Investors by 4.2% in the second quarter. Trinity Legacy Partners LLC now owns 96,260 shares of the real estate investment trust’s stock worth $3,723,000 after purchasing an additional 3,874 shares during the last quarter. Virtus ETF Advisers LLC purchased a new position in Omega Healthcare Investors in the second quarter worth $2,561,000. Pinebridge Investments L.P. grew its holdings in Omega Healthcare Investors by 1,056.9% in the second quarter. Pinebridge Investments L.P. now owns 12,147 shares of the real estate investment trust’s stock worth $446,000 after purchasing an additional 11,097 shares during the last quarter. Finally, United Capital Financial Advisers LLC grew its holdings in Omega Healthcare Investors by 34.2% in the second quarter. United Capital Financial Advisers LLC now owns 15,553 shares of the real estate investment trust’s stock worth $572,000 after purchasing an additional 3,966 shares during the last quarter. 69.94% of the stock is owned by institutional investors.
Several equities analysts have issued reports on OHI shares. Raymond James lifted their price target on shares of Omega Healthcare Investors from $42.00 to $44.00 and gave the stock a “strong-buy” rating in a report on Thursday. Zacks Investment Research lowered shares of Omega Healthcare Investors from a “buy” rating to a “hold” rating in a report on Wednesday, August 21st. Wells Fargo & Co lifted their price target on shares of Omega Healthcare Investors from $36.00 to $40.00 and gave the stock a “market perform” rating in a report on Friday, August 23rd. Finally, Berenberg Bank started coverage on shares of Omega Healthcare Investors in a report on Thursday. They issued a “buy” rating and a $47.00 price target on the stock. Seven research analysts have rated the stock with a hold rating, two have given a buy rating and one has issued a strong buy rating to the company’s stock. Omega Healthcare Investors currently has a consensus rating of “Hold” and a consensus price target of $40.04.
NYSE OHI opened at $41.16 on Friday. The firm’s fifty day simple moving average is $38.95 and its two-hundred day simple moving average is $37.18. The company has a current ratio of 2.78, a quick ratio of 2.78 and a debt-to-equity ratio of 1.17. Omega Healthcare Investors Inc has a 12-month low of $31.69 and a 12-month high of $41.67. The firm has a market capitalization of $8.77 billion, a P/E ratio of 13.54, a P/E/G ratio of 5.33 and a beta of 0.37.
Omega Healthcare Investors (NYSE:OHI) last released its quarterly earnings results on Tuesday, August 6th. The real estate investment trust reported $0.34 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.73 by ($0.39). Omega Healthcare Investors had a return on equity of 6.79% and a net margin of 29.38%. The firm had revenue of $191.81 million during the quarter, compared to analysts’ expectations of $190.46 million. During the same period in the prior year, the firm posted $0.75 earnings per share. Omega Healthcare Investors’s revenue for the quarter was down .5% compared to the same quarter last year. As a group, sell-side analysts predict that Omega Healthcare Investors Inc will post 2.96 earnings per share for the current fiscal year.
The business also recently disclosed a quarterly dividend, which was paid on Thursday, August 15th. Stockholders of record on Wednesday, July 31st were issued a dividend of $0.66 per share. This represents a $2.64 dividend on an annualized basis and a dividend yield of 6.41%. The ex-dividend date was Tuesday, July 30th. Omega Healthcare Investors’s dividend payout ratio (DPR) is presently 86.84%.
In other news, insider Michael Ritz sold 5,000 shares of the business’s stock in a transaction on Friday, August 23rd. The shares were sold at an average price of $40.50, for a total transaction of $202,500.00. Following the sale, the insider now directly owns 10,485 shares of the company’s stock, valued at $424,642.50. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CEO C Taylor Pickett sold 30,000 shares of the business’s stock in a transaction on Thursday, June 20th. The shares were sold at an average price of $38.00, for a total transaction of $1,140,000.00. Following the sale, the chief executive officer now directly owns 299,133 shares in the company, valued at $11,367,054. The disclosure for this sale can be found here. Insiders have sold 118,500 shares of company stock worth $4,586,300 over the last three months. Corporate insiders own 1.16% of the company’s stock.
About Omega Healthcare Investors
Omega is a real estate investment trust that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the US, as well as in the UK.
Featured Story: What is an investor looking for in an SEC filing?
Want to see what other hedge funds are holding OHI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Omega Healthcare Investors Inc (NYSE:OHI).
Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.